New York 2023-2024 Regular Session

New York Senate Bill S00927

Introduced

1/9/23

Refer

1/9/23

Refer

1/3/24

Caption

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

Latest NY S00927 Activity

View All Events: NY 2023-2024 Regular Session S00927

Companion Bills

NY A09075

Same As Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

Previously Filed As

NY A00738

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

NY A06475

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

VA HB2097

Health insurance; coverage requirements for prostate cancer screenings.

VA SB1314

Health insurance; coverage requirements for prostate cancer screenings.

WV SB464

Requiring insurance coverage for biomarker testing

MD HB830

Health Insurance - Genetic Testing and Cancer Imaging - Required Coverage

GA HB373

Insurance; annual prostate cancer screenings for certain men; require major medical coverage

MO SB406

Enacts provisions relating to insurance coverage of genetic screenings for cancer risk

HI HCR35

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

OH HB33

Require insurance coverage for certain prostate cancer screening

Similar Bills

No similar bills found.